SGLT2 inhibitors may be a better treatment option for some older, frail patients hospitalized with heart failure, according to a study presented at the 2025 annual meeting of the Heart Failure Society ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback